Drugs

Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs
People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications.
Prevalence of deprescribing claims made by Quebec community pharmacies
Study assesses deprescribing claims made by Quebec community pharmacies over a 23-month period, with identification of the most commonly deprescribed medications.

Should antivirals play a bigger role in reducing family transmission influenza?

Study underlines the complementary role of antivirals can play in the fight against influenza pandemics, while also examining concerns about drug-resistant viruses.
Efficacy of biological agents to treat psoriasis varies with age: study

Treatment expectations, tolerance, side-effects and more are different across patient ages, British study shows.
What’s behind Ontario’s ‘relatively stable’ abortion rate as other U.S., European areas see spikes?

The abortion rate in Ontario has risen only slightly amid an expansion of abortion services across the country, according to research from the University of British Columbia.
QUIZ: Tackling acetaminophen toxicity

How much do you know about the latest recommendations on assessment and treatment of this common cause of drug-induced liver injury?
Growing tumours in egg provides rapid clues to personalized pediatric cancer treatment

Canadian researchers analyzing proteins identified an antidepressant as a treatment.
Rapid results from upadacitinib in the treatment of eczema

The JAK inhibitors showed efficacy as a monotherapy and also for facial eczema.
Fezolinetant vs. elinzanetant for vasomotor symptoms in menopausal women

New research looked to discover whether there were significant differences in efficacy between the two treatment options.
Botox injections could relieve severe dysmenorrhea—and healthcare costs

Botulinum toxin could reduce pelvic pain and improve women's quality of life, at a lower cost than current treatments.

Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs

Prevalence of deprescribing claims made by Quebec community pharmacies

Should antivirals play a bigger role in reducing family transmission influenza?

Efficacy of biological agents to treat psoriasis varies with age: study

What’s behind Ontario’s ‘relatively stable’ abortion rate as other U.S., European areas see spikes?

QUIZ: Tackling acetaminophen toxicity

Growing tumours in egg provides rapid clues to personalized pediatric cancer treatment

Rapid results from upadacitinib in the treatment of eczema

Fezolinetant vs. elinzanetant for vasomotor symptoms in menopausal women

Botox injections could relieve severe dysmenorrhea—and healthcare costs